{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "GBp", "marketState": "POSTPOST", "regularMarketChange": -1.0, "regularMarketTime": 1683905046, "regularMarketDayHigh": 19.0, "regularMarketDayRange": "17.2 - 19.0", "regularMarketDayLow": 17.2, "regularMarketVolume": 475314, "regularMarketPreviousClose": 18.375, "bid": 17.0, "ask": 17.75, "bidSize": 0, "askSize": 0, "fullExchangeName": "LSE", "financialCurrency": "GBP", "regularMarketOpen": 18.674, "averageDailyVolume3Month": 465175, "averageDailyVolume10Day": 578585, "fiftyTwoWeekLowChange": 6.04, "fiftyTwoWeekLowChangePercent": 0.5328628, "fiftyTwoWeekRange": "11.335 - 30.625", "fiftyTwoWeekHighChange": -13.25, "fiftyTwoWeekHighChangePercent": -0.43265307, "fiftyTwoWeekLow": 11.335, "fiftyTwoWeekHigh": 30.625, "exchange": "LSE", "shortName": "SKINBIOTHERAPEUTICS PLC ORD 1P", "longName": "SkinBioTherapeutics Plc", "messageBoardId": "finmb_403809930", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketChangePercent": -5.442177, "regularMarketPrice": 17.375, "earningsTimestamp": 1679983211, "earningsTimestampStart": 1679983211, "earningsTimestampEnd": 1679983211, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.02, "epsCurrentYear": -1.67, "priceEpsCurrentYear": -10.404192, "sharesOutstanding": 173139008, "bookValue": 0.008, "fiftyDayAverage": 17.6628, "fiftyDayAverageChange": -0.28779984, "fiftyDayAverageChangePercent": -0.016294124, "twoHundredDayAverage": 19.313225, "twoHundredDayAverageChange": -1.9382248, "twoHundredDayAverageChangePercent": -0.10035739, "marketCap": 30082904, "priceToBook": 2171.875, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1491375600000, "priceHint": 2, "symbol": "SBTX.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "The Core", "address2": "Bath Lane Newcastle Helix", "city": "Newcastle upon Tyne", "zip": "NE4 5TF", "country": "United Kingdom", "phone": "44 19 1495 7325", "website": "https://www.skinbiotherapeutics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health. It develops SkinBiotix technology that can enhance the formation of multi-protein complexes and prevent passage toxins, molecules, and ions, as well as pathogens; and AxisBiotix that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has a collaboration agreement with Croda Plc; and the University of Manchester to develop bacterial lysates in the prevention of periodontal gun disease. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stuart John Ashman", "age": 55, "title": "CEO & Exec. Director", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 325846, "fmt": "325.85k", "longFmt": "325,846"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Manprit Singh Randhawa", "age": 38, "title": "CFO, Sec. & Director", "yearBorn": 1984, "fiscalYear": 2022, "totalPay": {"raw": 177982, "fmt": "177.98k", "longFmt": "177,982"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Catherine  O'Neill", "title": "Chief Scientific Officer & Member of Scientific Advisory Board", "fiscalYear": 2019, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}